Skip to main content
Log in

Clinical application of quantitative coronary angiography using the CAAS system: Preliminary results of the INTACT study (international nifedipine trial on antiatherosclerotic therapy)

  • Published:
The International Journal of Cardiac Imaging Aims and scope Submit manuscript

Summary

It is the objective of the INTACT-study to test in man, whether a significant retardation of the progression of coronary artery disease is attainable with the Ca-antagonist nifedipine; this may be possible on the basis of numerous animal experiments. INTACT is a prospective, randomized, double blind, placebo controlled investigation in 423 patients with preferably early stages of coronary sclerosis in whom a progression of the disease seems likely. A proper coronary angiogram led to inclusion of the patients in the study (October 1983–June 1985). Over the following 3-years-period patients received either nifedipine 80 mg/day or placebo. The study is concluded by a control coronary angiogram with angiographic projections which are identical to those of the first coronary angiography. The extent of coronary sclerosis is objectivated by computer-assisted quantitative measurement of the entire coronary arterial system with the CAAS-system (Rotterdam). For definition purposes the coronary artery system subdivided into 25 segments. Parameters for progression assessment will be mean segment diameter, minimal obstruction diameter, percentage severity of obstruction, length of obstruction and plaque area.

So far 4826 coronary segments have been analyzed from the first angiograms of 383 patients. Per patient an average of 12.6 different segments could be evaluated in at least one angiographic projection. The major coronary segments could be measured in 72–93% of the patients in one or more angiographic projections (at the average about 2 different projections). Five hundred and forty-six coronary obstructions were analyzed; 131 of these were total occlusions. Only 9% of the length of the vessel contours detected by the computer algorithm required manual correction by the operators, suggesting a high reliability of the system. It can be concluded that quantitative measurement of the complete coronary artery system can indeed be obtained in a large angiographical multicenter study such as INTACT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bruschke AV, Wijers TS, Klosters W, Landman J. The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 non operated patients. Circulation 1981; 63: 527–536.

    PubMed  Google Scholar 

  2. Kramer JR, Matsuda U, Mulligan JC, Aronow M, Proudfit WC. Progression of coronary atherosclerosis. Circulation 1981; 63: 519–526.

    PubMed  Google Scholar 

  3. Moise A, Theroux P, Taeymans Y, Waters DD, Lespérance J, Fines P, Descoings B, Robert P. Clinical and angiographic factors associated with progression of coronary artery disease. J Am Coll Cardiol 1984; 3: 659–667.

    PubMed  Google Scholar 

  4. Nellessen U, Rafflenbeul W, Hecker H, Lichtlen P. Zur Progression der Koronarsklerose. Untersuchungen bei 19 Patienten über 6 Jahre mittels quantitativer Koronarangiographie. Z Kardiol 1984; 73: 760–767.

    PubMed  Google Scholar 

  5. Levy RI, Brensike JF, Epstein STE et al. The influence of changes in lipid values induced by cholestpyramine and diet on progression of coronary artery disease: results on the NHLBI-type II coronary intervention study. Circulation 1984; 69: 325–336.

    PubMed  Google Scholar 

  6. Arntzenius AC, Kromhout D, Barth JD et al. Diet, lipoproteins and the progression of coronary atherosclerosis. The Leiden intervention trial. N Engl J Med 1985; 312: 805–811.

    PubMed  Google Scholar 

  7. Kromhout D, Bosschieter EB, Lezenne Coulander C. The inverse relation between fish consumption and 20 year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205–1209.

    PubMed  Google Scholar 

  8. Kushi LH, Lew RA, Stare FJ et al. Diet and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 811–818.

    PubMed  Google Scholar 

  9. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. JAMA 1982; 248: 1546–1577.

    Google Scholar 

  10. Brensike JF, Levy RI, Kelsey SF et al. Effects of therapy with cholestyramine on progression of coronary atherosclerosis: results of the NHLBI-type II coronary intervention study. Circulation 1984; 69: 313–324.

    PubMed  Google Scholar 

  11. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results. JAMA 1984;251: 351–364.

    Google Scholar 

  12. Kramsch DM, Aspen AJ, Epstein CS. Suppression of experimental atherosclerosis by the calcium-antagonist Lanthanum. J Clin Invest 1980; 65: 967–981.

    PubMed  Google Scholar 

  13. Henry PD, Bentley K. Suppression of atherosclerosis in cholesterol-fed rabbits treated with nifedipine. J Clin Invest 1981; 68: 1366–1369.

    PubMed  Google Scholar 

  14. Rouleau JL, Parmley WW, Stevens J, Wikman-Coffelt J, Sievers R, Mahley RW, Havel RJ. Verapamil suppresses atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 1983; 6: 1453–1460.

    Google Scholar 

  15. Willis AL, Nagel B, Churchill V, Whyte MA, Smith DL, Mahmud I, Puppione DL. Anti-atherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits. Arteriosclerosis 1985; 5: 250–255.

    PubMed  Google Scholar 

  16. Fleckenstein A. Calcium antagonism in heart and smooth muscle. Interscience 1983; 2: 272–279.

    Google Scholar 

  17. Lichtlen PR, Nellessen U, Rafflenbeul W. International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Study design and baseline values. In: Lichtlen PR, ed. 6th International Adalat Symposium. Amsterdam: Excerpta Medica, 1985: 462–476.

    Google Scholar 

  18. Lichtlen PR, Nellessen U, Rafflenbeul W, Jost S, Hecker H. International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Cardiovasc Drug Ther 1987; 1: 71–79.

    Google Scholar 

  19. Reiber JHC, Kooijman CJ, Slager CJ, Gerbrands JJ, Schuurbiers JCH, Boer A den, Wijns W, Serruys PW, Hugenholtz PG. Coronary artery dimensions from cineangiograms-methodology and validation of a computer-assisted analysis procedure. IEEE Trans Med Imaging 1984; MI-3: 131–141.

    Google Scholar 

  20. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, Schuurbiers JCH, Boer A den, Hugenholtz PG. Assessment of short-, medium- and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985; 71: 280–288.

    PubMed  Google Scholar 

  21. Jost S, Rafflenbeul W, Knop I, Bossaller C, Schröder E, Gulba D, Hecker H, Lippolt P, Lichtlen PR. Correlation of plasma levels of isosorbide dinitrate to coronary dilation after administration of 10 mg in chewing-capsules. Eur Heart J, in press.

  22. Rafflenbeul W, Lichtlen PR. Release of residual vascular tone in coronary artery stenoses with nifedipine and glyceryl trinitrate. In: Kaltenbach M, Neufeld HN, eds. 5th International Adalat Symposium, Amsterdam: Excerpta Medica, 1983: 300–308.

    Google Scholar 

  23. Lichtlen PR, Rafflenbeul W. Effects of calcium antagonists on fixed and dynamic obstructions in patients with severe coronary artery disease. In: Cardiovascular effects of dihydropyridine-type calcium antagonists and agonists. Berlin: Springer-Verlag, 1985; 381–407.

    Google Scholar 

  24. Serruys PW, Reiber JHC, Wijns W, Brand M van den, Kooijman CJ, Katen HJ ten, Hugenholtz PG. Assessment of percutaneous transluminal coronary angioplasty by quantitative coronary angiography: diameter versus densitometric area measurements. Am J Cardiol 1984; 54: 482–488.

    PubMed  Google Scholar 

  25. Wijns W, Serruys PW, Reiber JHC, Brand M van den, Simoons ML, Kooijman CJ, Balakumaran K, Hugenholtz PG. Quantitative angiography of the left anterior descending coronary artery: correlations with pressure gradient and exercise thallium scintigraphy. Circulation 1985; 71: 273–279.

    PubMed  Google Scholar 

  26. Rafflenbeul W, Smith LR, Rogers WJ, Mantle JA, Rackley LE, Russel RO. Quantitative coronary angiography: coronary anatomy of unstable angina pectoris one year after optimal medical therapy. Am J Cardiol 1979; 43: 699–707.

    PubMed  Google Scholar 

  27. Rafflenbeul W, Urthaler F, Lichtlen P, James TN. Quantitative differences in ‘critical’ stenosis between right and left coronary artery in man. Circulation 1980; 62: 1188–1196.

    PubMed  Google Scholar 

  28. Austen WG, Edwards JE, Frye RL et al. A reporting system on patients evaluated for coronary artery disease: report of the Ad Hoc Committee for Grading of Coronary Artery Disease. Council on Cardiovascular Surgery. Am Heart Assoc. Circulation 1975; 51 Suppl: 5–40.

    Google Scholar 

  29. Reiber JHC, Slager CJ, Schuurbiers JCH, Boer A den, Gerbrands JJ, Troost GJ, Scholts B, Kooijman CJ, Serruys PW. Transfer functions of the X-ray cine video chain applied to digital processing of coronary cineangiograms. In: Heintzen PH, Brennecke R, eds. Digital imaging in cardiovascular radiology. Stuttgart: Georg Thieme Verlag, 1983: 89–104.

    Google Scholar 

  30. Freudenberg H, Lichtlen P. Das normale Wandsegment bei Koronarstenosen — eine postmortale Studie. Z Kardiol 1981; 70: 863–869.

    PubMed  Google Scholar 

  31. Detre KM, Wright E, Murphy ML, Takaro T. Observer agreement in evaluating coronary angiograms. Circulation 1975; 52: 979–986.

    PubMed  Google Scholar 

  32. Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW. Interobserver variability in coronary angiography. Circulation 1976; 53: 627–632.

    PubMed  Google Scholar 

  33. De Rouen TA, Murray JA, Owen W. Variability in the analyses of coronary arteriograms. Circulation 1977; 55: 324–328.

    PubMed  Google Scholar 

  34. Rafflenbeul W, Dzuiba M, Henkel B, Lichtlen P. Morphometric analysis of coronary obstructions during life. Circulation 1975; 51/52: II-27.

    Google Scholar 

  35. Rafflenbeul W, Heim R, Dzuiba M, Henkel B, Lichtlen P. Morphometric analysis of coronary arteries. In: Lichtlen PR, ed. Internat Symp on Coronary Angiography, Hannover, March '74. Stuttgart: Thieme, 1974: 255 (abstract).

    Google Scholar 

  36. Ellis S, Sanders W, Goulet C, Miller R, Cain KC, Lespérance J, Bourassa MG, Alderman EL. Optimal detection of the progression of coronary artery disease: comparison of methods suitable for risk factor intervention trials. Circulation 1986; 74: 1235–1246.

    PubMed  Google Scholar 

  37. Spears JR, Sandor T, Baim BS, Paulin S. The minimal error in estimating coronary luminal cross sectional area from cineangiographic diameter measurements. Cathet Cardiovasc Diagn 1983; 9: 119–132.

    PubMed  Google Scholar 

  38. Christensen EE, Curry IS III, Dowdey JE. An introduction to the physics of diagnostic radiology, 2nd ed. Philadelphia: Lea and Febiger, 1978: 158–170.

    Google Scholar 

  39. Kober G, Vallbracht C, Lang H, Bussmann WD, Hopf R, Kunkel B, Kaltenbach M. Transluminale koronare Angioplastik 1977–1985. Radiologe 1985; 25: 346–353.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jost, S., Deckers, J.W., Nellessen, U. et al. Clinical application of quantitative coronary angiography using the CAAS system: Preliminary results of the INTACT study (international nifedipine trial on antiatherosclerotic therapy). Int J Cardiac Imag 3, 75–86 (1988). https://doi.org/10.1007/BF01814880

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01814880

Key words

Navigation